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ABSTRACT
Background: Although the number of patients requiring hospitalization due to asthma attacks has decreased
over the years, there are many who still require hospitalization for tracheal intubation and mechanical ventila-
tion following a severe asthma attack. Therefore, we evaluated the characteristics of patients with asthma who
required tracheal intubation and mechanical ventilation in our hospital.
Methods: We evaluated 20 patients who had severely exacerbated asthma, requiring tracheal intubation and
mechanical ventilation. An evaluation was made based on their smoking history, the number of days from the
onset of the asthma attack to admission, the level of asthma control, treatments before presenting to our hospi-
tal, the frequency of hospital visits, the reason for tracheal intubation and mechanical ventilation, and outcome.
Results: Of the 20 patients with asthma 13 were men and 7 women, with a mean age of 48.7 years. The char-
acteristics of patients who required tracheal intubation and mechanical ventilation were as follows:① smokers,
② not taking or irregularly taking medication,③ using inhaled short-acting β2agonist (SABA) alone as needed,
and④ not using inhaled corticosteroids (ICS).
Conclusions: Our findings suggest that treatment mainly using ICS, in addition to increased awareness of the
dangers of asthma among the patients themselves, are important in preventing severe asthma attacks requir-
ing tracheal intubation and mechanical ventilation.
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INTRODUCTION
Bronchial asthma is a common chronic inflammatory
condition characterized by variable airway narrowing
and hyper-responsiveness due to an underlying in-
flammatory process and bronchial structural change.
The clinical manifestations of asthma are daily respi-
ratory symptoms which affect the patient’s quality of
life. During an asthma attack, these symptoms be-
come more severe and can endanger the patient’s
life.
The prevalence of asthma in adults was reported to
be about 3.2% in Japan.1 Since the establishment of
the Asthma Prevention and Management Japanese
Guideline (JGL) in 1993, the number of inpatients
with a severe asthma attack has decreased in Japan.
However, there are still many who visit emergency
wards due to a severe asthma attack. The fatality rate
of asthma for every 100,000 population has decreased
and was approximately 2.6 in 2004.1 The widespread
use of inhaled corticosteroids (ICS) for long-term
asthma management is considered to be an important
factor for these improvements although there are still
many who require tracheal intubation and mechani-
cal ventilation following a severe asthma attack.
We evaluated the characteristics of 20 patients with
asthma who required tracheal intubation and me-
chanical ventilation in our hospital to determine how
this could be prevented.
Allergology International. 2009;58:289-294
ORIGINAL ARTICLE
1Department of Respiratory Medicine, Toho University Medical
Center, Tokyo and 2Clinical Research Center for Allergy and
Rheumatology, National Hospital Organization, Sagamihara Na-
tional Hospital, Kanagawa, Japan.
Correspondence: Kiyoshi Sekiya, Department of Respiratory
Medicine, Toho University Medical Center, Omori-Nishi 6−11−1,
Ota-ku, Tokyo 143−8541, Japan.
Email: k−sekiya@sagamihara−hosp.gr.jp
Received 6 October 2008. Accepted for publication 5 January
2009.
2009 Japanese Society of Allergology
DOI: 10.2332allergolint.08-OA-0052
Sekiya K et al.
290 Allergology International Vol 58, No2, 2009 www.jsaweb.jp
Table 1 Patient characteristics
Subjects (n＝20)Characteristics
(65)13Male, n (%) 
土6.948.7Age (yesrs), mean土SD
Types of asthma, n (%)
(45)9Atopic
(55)11Nonatopic
(70)14Curent smoker, n (%) 
(8/6)(male/female) 
(45)9History of child asthma, n (%) 
土635684Serum IgE (IU/ml), mean土SD
Number of days from the asthma
土0.72.2atack onset (days), mean土SD
(5)1History of tracheal intubation and 
respirator management, n (%) 
(0)0Aspirin intolerant asthma, n (%) 
Fig. 1 Age distribution chart (n＝20).
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METHODS
SUBJECTS
We selected 20 patients with asthma who visited our
hospital from January 2001 to December 2005 and re-
quired tracheal intubation and mechanical ventilation.
All patients had severely exacerbated asthma, as de-
termined by the guidelines set by the Global Initiative
for Asthma (GINA) 2002,2 and required tracheal intu-
bation and mechanical ventilation. We evaluated their
smoking history, the number of days from the onset
of the asthma attack to admission, the level of asthma
control as determined by the GINA 2002 guidelines,
treatments given prior to the hospital visit, the fre-
quency of hospital visits, the reason for tracheal intu-
bation and mechanical ventilation, based on the
Asthma Prevention and Management Japanese
Guideline (JGL) 2003, and their prognosis.
TYPE OF ASTHMA
The type of asthma was determined based on the JGL
2003 classification. A marker of atopic asthma in JGL
2003 suggests the presence of specific IgE antibodies
to environmental allergens.
ASTHMA SEVERITY
We evaluated the severity of asthma by interviewing
patients, their family or both. The severity of asthma
was classified into four categories, intermittent, mild
persistent, moderate persistent, and severe persistent
in accordance with the classification of control levels
based on GINA 2002.
RESULTS
BACKGROUND FEATURES
Of the 20 patients with asthma 13 were men (65%)
and 7 women (35%), with an age range of 21―79
years, and mean age of 48.7 years (Fig. 1). The types
of asthma were atopic in 9 patients (45%) and nona-
topic in 11 patients (55%), and 14 patients (70%) were
current smokers. Six of the 7 women were current
smokers under the age of 60. Of the 13 male patients,
8 were current smokers of which 5 were under 60. A
total of 9 patients had a history of childhood asthma.
All patients were admitted to our hospital through the
emergency ward. The mean number of days from the
onset of the asthma attack to admission was 2.2 days
(range, 1―7 days). One patient had a history of tra-
cheal intubation and mechanical ventilation for a se-
vere asthma attack (5%). No patient had aspirin intol-
erant asthma (Table 1).
The most common cause triggering the asthma at-
tack was infection (Fig. 2).
The reasons for tracheal intubation and mechanical
ventilation, in accordance with the JGL2003, were as
follows: PaO2 was less than 50 torr despite maximum
oxygen administration (6 patients [30%]); a sudden
increase in PaCO2 followed by loss of consciousness
(4 patients [20%]); both of the above (5 patients
[25%]); extensive ventilatory disturbance or car-
diorespiratory arrest (5 patients [25%]) (Fig. 3).
ASTHMA SEVERITY
The severities of asthma before admission due to a
near-fatal asthmatic attack were as follows: intermit-
tent (8 patients [40%]); mild persistent (5 patients
[25%]); moderate persistent (6 patients [30%]); severe
persistent (1 patient [5%]). As for the severity of
asthma before presenting, those with mild persistent
asthma accounted for over 65% (Fig. 4).
STATUS OF ADHERENCE TO ASTHMA TREAT-
MENT
The status of patient adherence was as follows: no
treatment (6 patients [30%]); irregular visits to a clinic
(7 patients [35%]); regular visits to a medical institu-
tion (7 patients [35%]). Those who did not undergo
treatment and visited a clinic irregularly accounted
for 65% of the patients (Fig. 5).
The treatments undergone by patients before be-
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Fig. 2 Causes triggering asthma atacks (n＝20).
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Fig. 3 Reasons for tracheal intubation and respirator man
agement in accordance with the JGL 2003. 1, extensive ven
tilatory disturbance or cardiorespiratory arest; 2, clear 
respiratory muscle fatigue; 3, PaO2 of less than 50 tor de
spite maximum oxygen administration; 4, PaCO2 increasing 
to more than 5 tor for 1 hour; 5, sudden increase in PaCO2 
folowed by loss of consciousness.
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Fig. 4 Asthma severity before a near-fatal atack. The 
classification of asthma control was determined from the 
GINA 2002 guidelines (n＝20).
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ing admitted to our hospital were as follows: no treat-
ment (6 patients [30%]); using short-acting inhaled β2
agonists (SABA) alone as needed (7 patients [35%]);
continuous use of oral theophylline and use of SABA
as needed (5 patients [25%]); continuous use of ICS
and leukotriene receptor antagonists (LTRA) (1 pa-
tient [5%]); continuous use of ICS, long-acting inhaled
β2 agonists (LABA), oral theophylline, and LTRA (1
patient [5%]) (Fig. 6). Only 2 patients (10%) used ICS
continuously.
OUTCOME
Two patients (10%) died despite tracheal intubation,
respirator management, and intensive drug therapy.
These 2 patients had cardiorespiratory arrest immedi-
ately after arrival at the hospital.
DISCUSSION
Patients who required tracheal intubation and me-
chanical ventilation had the following characteristics:
① smokers, ② not taking or irregularly taking medi-
cation, ③ using SABA alone as needed, and ④ not
using ICS.
In recent years, the prevalence of asthma has been
increasing. On the other hand, the fatality rate of
asthma for every 100,000 population has decreased
and was approximately 2.6 in 2004.1 The reasons for
the decrease in the fatality rate of asthma are the es-
tablishment of the Asthma Prevention and Manage-
ment Japanese Guidelines in 1993, and the wide-
spread use of inhaled glucocorticosteroids as medica-
tion for long-term management. However, more than
3,000 patients still die annually in Japan. According to
a report by the Japanese Society of Allergology, the
risk factors for asthma death are advanced age, male
gender, severe asthma, nonatopic type asthma, and
previous hospitalization for a near-fatal asthma attack.
Concerning the time and place of death, 28.9% died
before arrival, 19.4% died in the emergency room,
and 38.6% died during hospitalization.3 We evaluated
the risk factors in the 20 patients who required tra-
cheal intubation and respirator management because
of a severe asthma attack in our hospital, as identify-
ing such risk factors may lead to the prevention of a
severe asthma attack.
Patients consisted of many men. In Japan, more
men than women have died from asthma in the past
30 years. However, the number of male deaths was
slightly lower than that of female deaths in 2002. The
result of this study showed there have been more
cases of men with near-fatal attacks than women. The
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292 Allergology International Vol 58, No2, 2009 www.jsaweb.jp
Fig. 5 Frequencies of hospital visits (n＝20).
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Fig. 6 Treatments undergone by patients before  present-
ing to our hospital (n＝20). SRT, slow-release theophyline.
No treatment
30%SRT, SABA
25%
ICS, LTRA
5%
SABA alone
35%
ICS, LABA,
LTRA, SRT
5%
smoking rate is higher in men than in women. The
subjects of this study included many smokers, of
which there were more men. Most of the men were
over 60 years old. Moreover, we believe that men
show poor adherence as a result of work and con-
sider this the reason why there are many cases of
men having severe attacks.
The reason for this is yet to be clarified. Additional
studies will need to be carried out in the future to in-
vestigate this issue.
Seventy percent of the patients were smokers. In
particular, 6 of the 7 women were current smokers
and under the age of 60. Many fatal asthma cases are
over the age of 60 in Japan.1 It is suggested that
smoking in women is a risk factor for near-fatal
asthma. A recent study has shown that smoking sup-
presses the efficacy of glucocorticosteroids. Cigarette
smoking is responsible for the development and per-
sistence of airway inflammation. In general, patients
with asthma are negatively affected by cigarette
smoke. Even nonsmoking patients with asthma may
have significant exposure to passive smoke.4
For example, acute exposure to cigarette smoke
triggers bronchoconstriction and symptoms in people
with asthma.5,6 Active cigarette smoking has detri-
mental effects on asthma morbidity. Compared with
nonsmokers with asthma, smokers with asthma have
more severe symptoms,7,8 such as increased number
of hospitalization,9 accelerated decline in lung func-
tion,10,11 and impaired therapeutic responses to in-
haled12,13 and oral corticosteroids.14
Particularly high rates of smoking have been noted
in adults admitted to emergency departments with
acute asthma.9 It was reported that asthmatic symp-
toms and bronchial hyperreactivity improved after
smoking cessation.15 Furthermore, it was reported
that the response to ICS is attenuated in mild asthma
patients who smoke.16 It was considered that smok-
ing exacerbated asthma in patients.
As for the severity of asthma before the near-fatal
attack, most of the patients had intermittent asthma,
and those with severe persistent asthma were fewest.
These results suggest that a severe asthma attack can
occur in any type of patient regardless of the fre-
quency of asthma attack. Regarding the frequency of
hospital visits, 65% had received no treatment and vis-
ited a hospital only irregularly. Regarding treatment
before visiting our hospital, 65% had received no
treatment and only used SABA alone as needed.
SABAs have been associated with rebound hyper-
responsiveness,17 worsening of severity,18,19 and in-
creased risk of death.20 Available evidence suggests
that the more recently introduced LABAs do not in-
crease the risk of death,21 while the use of ICS is as-
sociated with a reduction in mortality.22,23 The results
of this study are consistent with those of previous re-
ports. The tendency for increased deaths in patients
with prescribed β-agonists alone and fewer deaths in
those taking β-agonists with inhaled corticosteroids
have been reported.24
Moreover, we observed that the daily control of air-
way inflammation is important. At present, it is con-
sidered that ICS is the most important medicine for
long-term management of asthma. It was also re-
ported that the numbers of emergency visits and hos-
pitalizations due to asthma have decreased.25-27 How-
ever, there were only 2 patients in our study who
used ICS (10%). This emphasizes the importance of
ICS for long-term management of asthma. There is
evidence showing that early treatment of asthma with
ICS may help to prevent chronic airway obstruction.28
The latter report supports the current asthma treat-
ment strategy advocating the early introduction of
ICS. However, little is mentioned concerning this,
and therefore, further accumulation of cases is neces-
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sary. Cushley29 and Stableforth30 stated that sufficient
educational guidance, so that the patients themselves
can clearly understand the severity of seizures, is
necessary to prevent death due to asthma. Therefore,
we believe that educating patients about the manage-
ment and treatment of asthma is important. Under-
standing the terror of an asthma attack through expe-
rience is insufficient. We consider basic pathologic
explanation of asthma using simple pamphlets to be
effective as it is important to gain knowledge about
asthma. Moreover, we consider that self-management
is important to make patients think about the man-
agement of asthma attacks. We instructed patients to
record their symptoms and measure their peak flow
everyday (PEF), thus enabling them to take note of
the aggravation of symptoms and decrease in PEF.
An early visit to a medical institution is also crutial
and we strongly advised regular hospital visits to con-
firm guidance results, as monitoring the progress of
these effects is necessary.
Mechanical ventilation can improve poor prognosis
of patients with severe asthma, and it is an important
means of preventing asthma death. Since tracheal in-
tubation and mechanical ventilation can open the air-
way and provide effective oxygenation, they can in-
crease the effective alveolar ventilation volume and fa-
cilitate breathing. However, tracheal intubation also
has risks in addition to the fact that high-pressure
ventilation using a mechanical ventilation may pro-
mote barotrauma. Therefore, the adaptation of a pa-
tient to tracheal intubation and mechanical ventilation
must be strictly determined. In this study, 2 out of the
20 patients died (10%), both from cardiorespiratory
arrest immediately after their arrival at the hospital.
Mechanical ventilation and tracheal intubation are ef-
fective means of treating a lethal asthma attack if the
adaptation of a patient to these interventions can be
determined adequately.
Our findings suggest that treatment using mainly
ICS in addition to increased awareness of the dangers
of asthma among patients themselves are important
in preventing a severe asthma attack requiring tra-
cheal intubation and mechanical ventilation.
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